SIM
ONCT

Spark Investment Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Spark Investment Management’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-46
Closed -$44K – 859
2015
Q4 		$44K Buy
46
+2
+5% +$2.64K 0.01% 720
2015
Q3 		$46K Buy
+44
New +$64.3K 0.01% 646
2015
Q1 		– Sell
-24
Closed -$23K – 777
2014
Q4 		$23K Buy
+24
New +$21.4K ﹤0.01% 667

Other funds holding ONCT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FHA
First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Spark Investment Management's ONCT Position: Q1 2016 in Review

Spark Investment Management sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2016, closing a stake of 46 shares — an estimated $44K sold.

Spark Investment Management first reported a position in ONCT in Q4 2014 and held it in 3 quarters. The position peaked at $46K in Q3 2015. 36 funds tracked by Wall St. Rank hold ONCT as of Q1 2016.

  • Spark Investment Management reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 46 Oncternal Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $44K.
  • Spark Investment Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2014 and held it in 3 quarters.
  • Spark Investment Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $46K in Q3 2015.
  • 36 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.